The CARMAT-Total Artificial Heart (C-TAH) is designed to provide heart replacement therapy for patients with end-stage biventricular failure. This report details the reliability and efficacy of the autoregulation device control mechanism (auto-mode), designed to mimic normal physiologic responses to changing patient needs. Hemodynamic data from a continuous cohort of 10 patients implanted with the device, recorded over 1,842 support days in auto-mode, were analyzed with respect to daily changing physiologic needs. The C-TAH uses embedded pressure sensors to regulate the pump output. Right and left ventricular outputs are automatically balanced. The operator sets target values and the inbuilt algorithm adjusts the stroke volume and beat rate, and hence cardiac output, automatically. Auto-mode is set perioperatively after initial postcardiopulmonary bypass hemodynamic stabilization. All patients showed a range of average inflow pressures of between 5 and 20 mm Hg during their daily activities, resulting in cardiac output responses of between 4.3 and 7.3 L/min. Operator adjustments were cumulatively only required on 20 occasions. This report demonstrates that the C-TAH auto-mode effectively produces appropriate physiologic responses reflective of changing patients' daily needs and represents one of the unique characteristics of this device in providing almost physiologic heart replacement therapy.

Carmat SA Vélizy France; and ¶Department of Anesthesiology and Intensive Care Medicine Institute for Clinical and Experimental Medicine Prague Czech Republic

From the Department of Cardiovascular Surgery Institute for Clinical and Experimental Medicine Prague Czech Republic

Georges Pompidou European Hospital Paris France

National Research Cardiac Surgery Center Kazakhstan

ASAIO J. 2021 Oct 1;67(10):1109-1110. doi: 10.1097/MAT.0000000000001579. PubMed

See more in PubMed

Carpentier A, Latrémouille C, Cholley B, et al. : First clinical use of a bioprosthetic total artificial heart: Report of two cases. Lancet 2015.386: 1556–1563. PubMed

Smadja DM, Susen S, Rauch A, et al. : The carmat bioprosthetic total artificial heart is associated with early hemostatic recovery and no acquired von Willebrand syndrome in calves. J Cardiothorac Vasc Anesth 2017.31: 1595–1602. PubMed

Bizouarn P, Roussel JC, Trochu JN, Perlès JC, Latrémouille C: Effects of pre-load variations on hemodynamic parameters with a pulsatile autoregulated artificial heart during the early post-operative period. J Heart Lung Transplant 2018.37: 161–163. PubMed

Canada JM, Evans RK, Abbate A, et al. : Exercise capacity in patients with the total artificial heart. ASAIO J 2018.65: 36–42. PubMed

Lavee J, Mulzer J, Krabatsch T, et al. : An international multicenter experience of biventricular support with HeartMate 3 ventricular assist systems. J Heart Lung Transplant 2018.37: 1399–1402. PubMed

Shehab S, Macdonald PS, Keogh AM, et al. : Long-term biventricular HeartWare ventricular assist device support–Case series of right atrial and right ventricular implantation outcomes. J Heart Lung Transplant 2016.35: 466–473. PubMed

Latrémouille C, Carpentier A, Leprince P, et al. : A bioprosthetic total artificial heart for end-stage heart failure: Results from a pilot study. J Heart Lung Transplant 2018.37: 33–37. PubMed

Tran HA, Pollema TL, Silva Enciso J, et al. : Durable biventricular support using right atrial placement of the HeartWare HVAD. ASAIO J 2017.64: 323–327. PubMed

Soucy KG, Koenig SC, Giridharan GA, Sobieski MA, Slaughter MS: Defining pulsatility during continuous-flow ventricular assist device support. J Heart Lung Transplant 2013.32: 581–587. PubMed

Cheng A, Trivedi JR, Van Berkel VH, Massey HT, Slaughter MS: Comparison of total artificial heart and biventricular assist device support as bridge-to-transplantation. J Card Surg 2016.31: 648–653. PubMed

Ng BC, Kleinheyer M, Smith PA, Timms D, Cohn WE, Lim E: Pulsatile operation of a continuous-flow right ventricular assist device (RVAD) to improve vascular pulsatility. PLoS One 2018.13: e0195975. PubMed PMC

Sorensen EN, Dees LM, Kaczorowski DJ, Feller ED: The heartware lavare cycle: A cautionary tale. ASAIO J 2020.66: e114–e116. PubMed

Arabía FA, Cantor RS, Koehl DA, et al. : Interagency registry for mechanically assisted circulatory support report on the total artificial heart. J Heart Lung Transplant 2018.37: 1304–1312. PubMed

Demondion P, Fournel L, Niculescu M, Pavie A, Leprince P: The challenge of home discharge with a total artificial heart: The La Pitie Salpetriere experience. Eur J Cardiothorac Surg 2013.44: 843–848. PubMed

Smith EM, Franzwa J: Chronic outpatient management of patients with a left ventricular assist device. J Thorac Dis 2015.7: 2112–2124. PubMed PMC